UAE's strategic stockpile of medicines, medical supplies is secure, sufficient: EDE

'The UAE’s pharmaceutical ecosystem is capable of responding efficiently to various regional and global developments,' said EDE's Director-General
- PUBLISHED: Wed 18 Mar 2026, 7:39 AM UPDATED: Wed 18 Mar 2026, 7:45 AM
- By:
- WAM
[Editor's Note: Follow Khaleej Times live blog amid US-Israel-Iran war for the latest regional developments.]
As the US-Israel-Iran war enters its 19th day on Wednesday, March 18, pharmaceutical authorities in the UAE reassured the public on the nation's strategic stockpile of medicines and medical supplies.
UAE's strategic stockpile of medicines and medical supplies is secure and sufficient to meet local market needs, according to The Emirates Drug Establishment (EDE).
Dr Fatima Al Kaabi, Director-General of the Emirates Drug Establishment (EDE), has conducted field visits to a number of pharmaceutical factories across the UAE as part of the EDE’s proactive approach and strategic vision to ensure the sustainability of the country’s pharmaceutical ecosystem.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
During the tour, Al Kaabi was briefed by factory officials on current production capacity, future expansion plans and the advanced manufacturing technologies adopted in line with the highest international standards of quality and safety.
The UAE’s pharmaceutical ecosystem is capable of responding efficiently to various regional and global developments. The country has succeeded in strengthening the capabilities of local pharmaceutical manufacturers and establishing legislative and regulatory frameworks that support the continued growth of this sector
Dr Fatima Al Kaabi, Director-General Of The Emirates Drug Establishment (Ede)
Al Kaabi added: “The UAE’s pharmaceutical sector is stable and well-prepared, backed by an advanced regulatory system that ensures the steady availability of medicines to the community in line with the highest standards of quality and safety.”
She stated that the Emirates Drug Establishment will spare no effort to create an integrated regulatory environment that supports research and development in the pharmaceutical sector, while also advancing its regulatory and oversight policies in line with global best practices to safeguard the safety, quality and effectiveness of locally manufactured medicines.
These visits are part of the Emirates Drug Establishment’s efforts to promote cooperation and integration with the industrial sector, helping to build an advanced healthcare ecosystem based on innovation, knowledge and sustainability, and reinforcing the UAE’s position as a leading regional hub for the healthcare and pharmaceutical sectors.




